Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moderate-dose cyclophosphamide for childhood acquired aplastic anemia
NCT01995331Phase 4Unknown
- Start
- Mar 2012
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclophosphamide in aplastic anemia. Status: unknown.
02
Drugs
cyclophosphamide
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT01995331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01995331.